zoledronic acid has been researched along with Cancer of Nasopharynx in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, QY; Liang, YJ; Lin, C; Mai, HQ; Sun, XS; Tang, LQ | 1 |
| Chen, L; Chen, Z; Gao, H; Gu, Z; Huang, Y; Jacob, TJC; Liang, X; Tan, Q; Wang, L; Yang, X; Yu, M; Zhao, C; Zheng, Y; Zhu, L | 1 |
| Cheng, J; Wu, G; Wu, HG; Xue, J | 1 |
| Cao, JY; Chen, SP; Fu, LW; Li, MZ; Liu, L; Liu, ZG; Mi, YJ; Qian, CN; Shao, JY; Xia, YF; Zeng, MS; Zhang, H; Zhang, X | 1 |
| Chen, LK; Hou, X; Huang, Y; Li, S; Liao, H; Liu, JL; Xu, F; Xue, C; Zhang, L; Zhao, HY; Zhao, YY | 1 |
| Chen, JY; Hong, CQ; Huang, WL; Li, WB; Li, XY; Lin, YC; You, YJ | 1 |
| An, X; Cai, XY; Cai, YC; Cao, Y; Jiang, WQ; Jin, Y; Shi, YX; Tan, YT; Xia, Q | 1 |
| Chen, JY; Hong, CQ; Huang, WL; Li, XY; Lin, W; Lin, YC; Wang, HB | 1 |
| Huang, WL; Li, XY; Lin, SL; Lin, W; Lin, WZ; Lin, YC; Wang, HB | 2 |
| Mukherjee, K; Saha, A; Sonthalia, N; Talukdar, A | 1 |
2 trial(s) available for zoledronic acid and Cancer of Nasopharynx
| Article | Year |
|---|---|
[Clinical analysis of therapeutic effect of zoledronic acid combined with radiotherapy for metastatic bone cancer].
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Bone Regeneration; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Female; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Pain; Pain Management; Radiotherapy; Zoledronic Acid | 2008 |
Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Collagen Type I; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Nasopharyngeal Neoplasms; Peptides; Treatment Outcome; Zoledronic Acid | 2011 |
9 other study(ies) available for zoledronic acid and Cancer of Nasopharynx
| Article | Year |
|---|---|
Role of zoledronic acid in nasopharyngeal carcinoma patients with bone-only metastasis at diagnosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Proportional Hazards Models; Retrospective Studies; Zoledronic Acid | 2019 |
The apoptotic effect of Zoledronic acid on the nasopharyngeal carcinoma cells via ROS mediated chloride channel activation.
Topics: Apoptosis; Biological Transport; Cell Line, Tumor; Chloride Channels; Chlorides; Gene Knockdown Techniques; Humans; Hydrogen Peroxide; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Reactive Oxygen Species; Zoledronic Acid | 2018 |
Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Blotting, Western; Bone Density Conservation Agents; Cell Line, Tumor; Cell Survival; Cells, Cultured; Chromosomal Proteins, Non-Histone; Cisplatin; Diphosphonates; Drug Synergism; Enzyme Inhibitors; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Immunohistochemistry; Kaplan-Meier Estimate; Male; Methionine; Microfilament Proteins; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Young Adult; Zoledronic Acid | 2010 |
Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells.
Topics: Blotting, Western; Bone Density Conservation Agents; Carcinoma; Cell Adhesion; Cell Movement; Cell Proliferation; Diphosphonates; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Humans; Imidazoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2012 |
Zoledronic acid combined with chemotherapy bring survival benefits to patients with bone metastases from nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Prognosis; Proportional Hazards Models; Zoledronic Acid | 2011 |
[Inhibitory effects of zoledronic acid on cell proliferation and invasion in human nasopharyngeal carcinoma cell line HNE1].
Topics: Carcinoma; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2011 |
Zoledronic acid inhibits human nasopharyngeal carcinoma cell proliferation by activating mitochondrial apoptotic pathway.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Flow Cytometry; Gene Expression; Humans; Imidazoles; In Situ Nick-End Labeling; Mitochondria; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Zoledronic Acid | 2012 |
[Study of sequence-dependent in vitro effects of zoledronic acid and paclitaxel upon human nasopharyngeal carcinoma cell line HNE1].
Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Zoledronic Acid | 2012 |
Treatment of hypertrophic osteoarthropathy in the case of pulmonary metastasis secondary-to-nasopharyngeal carcinoma with zoledronic acid: an enlightening experience.
Topics: Adult; Bone Density Conservation Agents; Carcinoma; Diagnosis, Differential; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Osteoarthropathy, Secondary Hypertrophic; Palliative Care; Tomography, X-Ray Computed; Zoledronic Acid | 2012 |